Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral ibandronate versus intravenous zoledronate for bone metastases from breast cancer
ISRCTN13914201Phase 3Completed
- Sponsor
- Velindre University NHS Trust
- Start
- Sep 2005
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial in breast cancer and bone metastases comparing Oral ibandronate with Intravenous zoledronate (2 arms). Primary endpoint: Mean number of skeletal related events per patient. Started Sep 2005; status: completed.
02
Drugs
ibandronatezoledronate
03
Conditions
breast cancerbone metastases
Beyond the preview
Go deeper on ISRCTN13914201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN13914201.